1. Live birth rate between the low-molecular-weight heparin and standard care group was comparable. 2. The most common inherited thrombophilia ...
1. Risk of venous thromboembolism in the antepartum and postpartum period was comparable between the intermediate- and low-dose low-molecular weight ...
In a group of hospitalized COVID-19 patients, a therapeutic dose of low-molecular-weight heparin reduced major thromboembolic events and death. Evidence ...
1. Among trauma patients aged 10 to 17, the use of low molecular weight heparin as compared with unfractionated heparin ...
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation dysfunction: ...
1. Anticoagulation at prophylactic dosing appeared to be associated with lower mortality and better prognosis in COVID-19 patients with coagulation ...
